Skip to main content
Premium Trial:

Request an Annual Quote

ABI President Cathy Burzik Steps Down; Applera CEO White Becomes Interim President

NEW YORK (GenomeWeb News) — Applied Biosystems President Cathy Burzik stepped down a little more than two years after being tapped to run the business after Mike Hunkapiller retired.
 
She left to take over as CEO of Kinetic, a San Antonio-based company specializing in advanced wound care and therapeutic surfaces.
 
Applera President and CEO Tony White has become interim president “partnering with the AB leadership team. ABI said the changes are effective immediately.
 
In a statement, White said ABI “has a strong management team and organizational structure and is performing well, and we expect to continue with the strategies and the team that have revitalized the business.”
 
He said he and ABI’s directors will “carefully consider our alternatives for the management succession.”
 
Burzik took over the helm of ABI after Michael Hunkapiller retired in August 2004. She joined ABI in September 2003 from Johnson & Johnson, where she was president of the company’s Ortho-Clinical Diagnostics business. Before being named president of ABI Burzik had been executive vice president and COO at ABI.
 
At Kinetic Burzik will replace Denny Ware, who had been planning to retire, Kinetic said in a statement.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.